Quantitative Analysis of Erythroblast Transcriptomes in Control and NUP-17d Treatment Groups
Ontology highlight
ABSTRACT: NUP-17d (17d) is an effective inhibitor of Plek2 protein. NUP-17d treatment inhibits erythroblast proliferation, differentiation and enucleation in a dose-dependent manner via directly binding to Plek2 protein. To reveal the detailed involving mechanism of NUP-17d treatment, we performed RNA sequencing to analyze the gene expression profiles change in erythroblasts which were treated with NUP-17d or DMSO (NC) for 48 hours in the EPO induction culture system.
ORGANISM(S): Mus musculus
PROVIDER: GSE176397 | GEO | 2021/06/09
REPOSITORIES: GEO
ACCESS DATA